Market Place
Sourcing Support
AbbVie launches ‘PSO Done’ Psoriasis Campaign
20 Apr 2026 //
FIERCE PHARMA
Abbvie`s Skyrizi Takes Full-Year TV Ad Spending Crown Yet Again
16 Jan 2026 //
FIERCE PHARMA
Botox Cosmetic Day Marks Biggest Annual Celebration on November
30 Oct 2025 //
PR NEWSWIRE
AbbVie Honors Patients, Scientists Behind Its Medicines
21 Aug 2025 //
FIERCE PHARMA
AbbVie`s Skyrizi, Novo`s Wegovy Top Q2 TV Ad Spending
16 Jul 2025 //
FIERCE PHARMA
Despite revision, UCPMP remains toothless: Alleges FMRAI
23 Jun 2025 //
PHARMABIZ
Abbvie Invites Migraine Sufferers to Enter Career Catalyst Award
03 Jun 2025 //
PRESS RELEASE
AbbVie to Present at Bank of America Healthcare Conference
06 May 2025 //
PRESS RELEASE
New Migraine Drugs Less Effective Than Triptans
19 Sep 2024 //
FIERCE PHARMA
DiMe, Big Pharmas collab on framework for digital endpoints
12 Jun 2024 //
FIERCE BIOTECH
HCPs conflicted on corporate messaging but admit its influence
20 May 2024 //
FIERCE PHARMA
AbbVie, Biohaven, Eli Lilly, Amgen lead push for attention in competitive space
01 Nov 2021 //
ENDPTS
A new gene therapy player debuts in LA with 2 startup VCs at its back, AbbVie
28 Apr 2021 //
ENDPTS
Big pharma alliance recruits first patients for unusual COVID-19 study
03 Aug 2020 //
BIOPHARMADIVE
The pharma world`s champion patent wall is called out for `drip-feed` strategy
23 Jul 2020 //
ENDPTS
Pharma`s TV ad spending level sets in June
16 Jul 2020 //
FIERCEPHARMA
3rd Circ. Mulling FTC-AbbVie Pause Till High Court Acts
14 Jul 2020 //
LAW360
Coronavirus: Hydroxychloroquine trial to restart
30 Jun 2020 //
BBC
Big Pharma Will Turn to Mergers After Crisis, Says RBC
24 Apr 2020 //
BARRONS
Evidence of a link between Parkinson`s disease & gut could inspire treatments
27 Jun 2019 //
FIERCE BIOTECH
Affinivax, Astellas begin clinical quest to beat Pfizer’s vaccine
13 Feb 2019 //
ENDPTS
AbbVie, Teneobio ink $90M deal to develop BCMA bispecific for multiple myeloma
12 Feb 2019 //
FIERCE BIOTECH
With 10th FDA OK, Imbruvica further expands in CLL
29 Jan 2019 //
BIOPHARMA DIVE
AbbVie wobbles as biosimilars bite Humira
29 Jan 2019 //
PHARMAPHORUM
Imbruvica regimen wins FDA approval 1st non-chemotherapy treatment for leukemia
28 Jan 2019 //
ENDPTS
AbbVie`s Imbruvica fails to meet main goal in pancreatic cancer study
19 Jan 2019 //
REUTERS
Short seller Citron draws fresh blood going after another biotech scalp
17 Jan 2019 //
ENDPTS
A biotech`s M&A invitation and Editas` next CRISPR step
12 Jan 2019 //
BIOPHARMA DIVE
AbbVie Is Helping, But It Is At Early Stage Of Development
11 Jan 2019 //
SEEKING ALPHA
IPO bonanza as biotechs get in while the iron’s hot
09 Jan 2019 //
FIERCE BIOTECH
AbbVie and J&J dominate clinical trial development in psoriatic arthritis
08 Jan 2019 //
GLOBAL DATA
Mega-blockbuster valuation AbbVie assigned to Rova-T starting to vanish, quietly
04 Jan 2019 //
ENDPTS
AbbVie seeks US and European authorisations for upadacitinib
22 Dec 2018 //
PHARMACEUTICAL-TECH
NeuClone Announces its 6th Biosimilar Candidate Perjeta for use in Combination Therapy with Herceptin
18 Dec 2018 //
PR NEWSWIRE
Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial
18 Dec 2018 //
REUTERS
AbbVie shows allure of pharma stock buybacks
13 Dec 2018 //
BIOPHARMA DIVE
Mini-Exodus From Biosimilar Space Stirs Questions
06 Dec 2018 //
RAPS
5 rheumatologists discuss the evolving landscape of RA treatment
30 Nov 2018 //
BIOPHARMA DIVE
Minimal Residual Disease: Application in Blood Cancers
30 Nov 2018 //
FIERCE BIOTECH
ASH 2018:A Guide to the Latest for Blood-Borne Cancers and More
26 Nov 2018 //
XCONOMY
Roche-AbbVie cancer drug gets accelerated FDA approval
22 Nov 2018 //
REUTERS
AbbVie enlists protein degradation experts at Mission for Alzhr’s, Parkinson’s
15 Nov 2018 //
ENDPTS
Medicines Patent Pool Signs Licence with AbbVie to Expand Hep-C Glecaprevir
12 Nov 2018 //
PR NEWSWIRE
Gilead`s HIV portfolio soars, but HCV sales falling?
27 Oct 2018 //
FIERCE PHARMA
AbbVie takes over cystic fibrosis drugs from Galapagos
26 Oct 2018 //
BIOPHARMA DIVE
AbbVie reaches 5th deal to secure Humira through 2023
19 Oct 2018 //
BIOPHARMA DIVE
New data keeps AbbVie’s star pipeline therapies on track
17 Sep 2018 //
PM LIVE
AbbVie Announces Data from Three Pivotal Phase 3 Studies of Risankizumab
13 Sep 2018 //
PR NEWSWIRE
AbbVie Presents Upadacitinib Longer-Term (32-Week) Data
13 Sep 2018 //
PR NEWSWIRE
Gilead, Galapagos’ filgotinib hits ph2 goals, but DVT case scares investors
07 Sep 2018 //
FIERCE BIOTECH
Upcoming events – Pivotal data readouts for Galapagos and Bayer
25 Aug 2018 //
EVALUATE PHARMA
Novartis just boasted of a big PhIII PI3K success
23 Aug 2018 //
ENDPTS
Preparing for the big biologic switch
17 Aug 2018 //
PHARMACEUTICAL JOURNAL
PARP inhibitors for ALS? Penn researchers post promising finds in brain disease
10 Aug 2018 //
ENDPTS
Cha-ching: Small biotechs write some of America`s biggest paychecks
07 Aug 2018 //
FIERCE PHARMA
Biosimilar Litigation Updates
01 Aug 2018 //
pH-Dependent Drug-Drug Interactions: Novartis, Merck, Gilead and More Weigh in
26 Jul 2018 //
RAPS
Novel Drug OK`d for Endometriosis Pain
24 Jul 2018 //
MEDPAGE TODAY
What`s more prescribed than opioids? Weirdly, a thyroid drug
26 Mar 2018 //
BIOPHARMADIVE
